Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis

MLA

Jeffrey T. Guptill, et al. “Effect of FcRn Antagonism on Protective Antibodies and to Vaccines in IgG-Mediated Autoimmune Diseases Pemphigus and Generalised Myasthenia Gravis.” Autoimmunity, vol. 55, no. 8, Nov. 2022, pp. 620–31. EBSCOhost, https://doi.org/10.1080/08916934.2022.2104261.

APA

Jeffrey T. Guptill, John W. Sleasman, Sophie Steeland, Magdalena Sips, Deborah Gelinas, Hans de Haard, Antoine Azar, & Kevin L. Winthrop. (2022). Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis. Autoimmunity, 55(8), 620–631. https://doi.org/10.1080/08916934.2022.2104261

Chicago

Jeffrey T. Guptill, John W. Sleasman, Sophie Steeland, Magdalena Sips, Deborah Gelinas, Hans de Haard, Antoine Azar, and Kevin L. Winthrop. 2022. “Effect of FcRn Antagonism on Protective Antibodies and to Vaccines in IgG-Mediated Autoimmune Diseases Pemphigus and Generalised Myasthenia Gravis.” Autoimmunity 55 (8): 620–31. doi:10.1080/08916934.2022.2104261.